首页> 外国专利> Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group

Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group

机译:用具有芥子碱,氮丙啶鎓或氮丙啶基团和核酸结合基团的化合物治疗血液或血液制品

摘要

Methods and compositions for treating pathogens in material are described, including methods of decontaminating human fluids prior to processing in the clinical laboratory and methods for decontaminating blood products prior to in vivo use. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating biological material are also contemplated which are compatible with clinical testing, in that they do not interfere with serum analytes.
机译:描述了用于处理材料中的病原体的方法和组合物,包括在临床实验室中处理之前对人的液体进行净化的方法以及在体内使用之前对血液产品进行净化的方法。该技术可处理大量人血清而不会影响测试结果。还考虑了用于光污染生物材料的新型化合物,它们与临床测试兼容,因为它们不干扰血清分析物。

著录项

  • 公开/公告号US2002182581A1

    专利类型

  • 公开/公告日2002-12-05

    原文格式PDF

  • 申请/专利权人 CERUS CORPORATION;

    申请/专利号US20020096196

  • 发明设计人 DAVID COOK;SUSAN WOLLOWITZ;AILEEN NERIO;

    申请日2002-03-12

  • 分类号A01N1/02;C12N5/08;

  • 国家 US

  • 入库时间 2022-08-22 00:08:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号